Nov 14, 2024 / 09:30PM GMT
Operator
Good afternoon, and thank you for joining the ReShape Lifesciences third-quarter 2024 Conference Call.
I would like to turn the call over to Michael Miller from Rx Communications.
Michael Miller - Rx Communications Group - Investor Relations
Good afternoon, everyone, and thank you for joining the third-quarter 2024 ReShape Lifesciences' earnings call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive Officer; and Tom Stankovich, Chief Financial Officer.
Management will also be joined by Krishna Gupta, a current Director of Vyome Therapeutics will be appointed Chairman of the combined company upon the completion of the previously announced merger agreement between the two companies.
As we do each quarter, Paul will provide an overview and update on the company's activities, and Tom will review the financial results for the period, after which, Paul will introduce Krishna for his remarks.
As a reminder, this conference call as well as ReShape Lifesciences' SEC filings and website, including the
Q3 2024 ReShape Lifesciences Inc Earnings Call Transcript
Nov 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers